June 8, 2015

Massachusetts Life Sciences Center and Dana-Farber Cancer Institute Announce Official Opening of Dana-Farber’s Molecular Cancer Imaging Facility

Boston, MA – The Dana-Farber Cancer Institute and the Massachusetts Life Sciences Center (MLSC) today celebrated the official opening of Dana-Farber’s Molecular Cancer Imaging Facility in Boston’s Innovation District.

The laboratory focuses on making chemical tracers that “light up” cancer cells and molecular pathways, a technology for research on improving cancer diagnosis and developing precision drugs matched to individual patients.

Interim Executive Director and Medical Director of the Boston Public Health Commission Dr. Huy Nguyen, MLSC Vice President for Communications and Marketing Angus McQuilken, Chief Scientific Officer at Dana-Farber Barrett Rollins, MD, Dana-Farber President and CEO Edward J. Benz Jr., MD. participate in a ribbon-cutting ceremony to celebrate the official opening of Dana-Farber’s Molecular Cancer Imaging Facility in Boston’s Innovation District.
Interim Executive Director and Medical Director of the Boston Public Health Commission Dr. Huy Nguyen, MLSC Vice President for Communications and Marketing Angus McQuilken, Chief Scientific Officer at Dana-Farber Barrett Rollins, MD, Dana-Farber President and CEO Edward J. Benz Jr., MD. participate in a ribbon-cutting ceremony to celebrate the official opening of Dana-Farber’s Molecular Cancer Imaging Facility in Boston’s Innovation District.